These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 24907404)

  • 21. Diagnosis of interstitial cystitis/bladder pain syndrome in women with chronic pelvic pain: a prospective observational study.
    Cheng C; Rosamilia A; Healey M
    Int Urogynecol J; 2012 Oct; 23(10):1361-6. PubMed ID: 22398828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
    Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small Fiber Polyneuropathy in Hunner Lesion and Non-Hunner Lesion Interstitial Cystitis/Bladder Pain Syndrome.
    Han E; Killinger KA; Turner KM; Gilleran J; Tenney D; Peters KM
    Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e91-e95. PubMed ID: 32217920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The c-Jun N-terminal kinase (JNK) pathway is activated in human interstitial cystitis (IC) and rat protamine sulfate induced cystitis.
    Zhao J; Wang L; Dong X; Hu X; Zhou L; Liu Q; Song B; Wu Q; Li L
    Sci Rep; 2016 Feb; 6():19670. PubMed ID: 26883396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep disturbances and nocturnal symptoms: relationships with quality of life in a population-based sample of women with interstitial cystitis/bladder pain syndrome.
    Troxel WM; Booth M; Buysse DJ; Elliott MN; Suskind AM; Clemens JQ; Berry SH
    J Clin Sleep Med; 2014 Dec; 10(12):1331-7. PubMed ID: 25325604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unsupervised Machine Learning Reveals a Vulvodynia-Predominant Subtype in Bladder Pain Syndrome/Interstitial Cystitis.
    Okui N
    Cureus; 2024 Jun; 16(6):e62585. PubMed ID: 39027744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences?
    Castro-Diaz D; Cardozo L; Chapple CR; Espuña M; Kelleher C; Kirby M; Milsom I; Sievert KD; Tubaro A
    Int J Clin Pract; 2014 Mar; 68(3):356-62. PubMed ID: 24373133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome.
    Jiang YH; Peng CH; Liu HT; Kuo HC
    PLoS One; 2013; 8(10):e76779. PubMed ID: 24146927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study.
    Ostardo E; Impellizzeri D; Cervigni M; Porru D; Sommariva M; Cordaro M; Siracusa R; Fusco R; Gugliandolo E; Crupi R; Schievano C; Inferrera A; Di Paola R; Cuzzocrea S;
    Pharmacol Res; 2018 Aug; 134():16-30. PubMed ID: 29800607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.
    Kim A; Shin DM; Choo MS
    Curr Urol Rep; 2016 Jan; 17(1):1. PubMed ID: 26686192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examination of pelvic floor muscle elasticity in patients with interstitial cystitis/bladder pain syndrome using real-time tissue elastography.
    Abe-Takahashi Y; Kitta T; Ouchi M; Chiba H; Higuchi M; Togo M; Shinohara N
    Int Urogynecol J; 2022 Mar; 33(3):619-626. PubMed ID: 33740121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of amitriptyline in treatment interstitial cystitis or bladder pain syndrome according to two criteria: does ESSIC criteria change the response rate?
    Sun Y; Fang Z; Ding Q; Zheng J
    Neurourol Urodyn; 2014 Mar; 33(3):341-4. PubMed ID: 23744795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purinergic P2X7 receptors as therapeutic targets in interstitial cystitis/bladder pain syndrome; key role of ATP signaling in inflammation.
    Taidi Z; Mansfield KJ; Bates L; Sana-Ur-Rehman H; Liu L
    Bladder (San Franc); 2019; 6(1):e38. PubMed ID: 32775480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidation of the pathophysiology of interstitial cystitis/bladder pain syndrome via experimental autoimmune cystitis rat model.
    Kadekawa K; Nishijima S; Noguchi K; Matsumoto S; Sugaya K
    Am J Physiol Regul Integr Comp Physiol; 2024 Aug; 327(2):R250-R260. PubMed ID: 38842512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion-Weighted Magnetic Resonance Imaging: A New Tool for the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis.
    Charlanes A; Boudghene F; Chesnel C; Ciofu C; Le Breton F; Jousse M; Amarenco G; Manceau P
    Urol Int; 2019; 102(1):109-112. PubMed ID: 30428470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compensatory coping and depression in women with interstitial cystitis/bladder pain syndrome.
    Sutherland S; Grace Kelly A; Ryden A; Dmochowski RR; Reynolds WS; McKernan LC
    Neurourol Urodyn; 2023 Jan; 42(1):322-329. PubMed ID: 36378850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping of pain phenotypes in female patients with bladder pain syndrome/interstitial cystitis and controls.
    Tripp DA; Nickel JC; Wong J; Pontari M; Moldwin R; Mayer R; Carr LK; Doggweiler R; Yang CC; Mishra N; Nordling J
    Eur Urol; 2012 Dec; 62(6):1188-94. PubMed ID: 22633363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.
    Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M
    Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
    Shie JH; Liu HT; Wang YS; Kuo HC
    BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological management of interstitial cystitis /bladder pain syndrome and the role cyclosporine and other immunomodulating drugs play.
    Ogawa T; Ishizuka O; Ueda T; Tyagi P; Chancellor MB; Yoshimura N
    Expert Rev Clin Pharmacol; 2018 May; 11(5):495-505. PubMed ID: 29575959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.